Clinical and experimental pharmacokinetic interaction between 6-mercaptopurine and methotrexate
- 1 March 1996
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 37 (5) , 409-414
- https://doi.org/10.1007/s002800050405
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapyThe Lancet, 1991
- Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemiaThe Lancet, 1990
- 6-Mercaptopurine Plasma Levels in Children with Acute Lymphoblastic LeukemiaTherapeutic Drug Monitoring, 1989
- Large Interindividual Variations in the Pharmacokinetics of Oral 6‐Mercaptopurine in Maintenance Therapy of Children with Acute Leukaemia and Non‐Hodgkin LymphomaActa Paediatrica, 1986
- Influence of Food Intake on Bioavailability of Oral 6-Mercaptopurine in Children with Acute Lymphoblastic LeukemiaPediatric Hematology and Oncology, 1986
- Analysis of 6-Mercaptopurine in Serum or Plasma Using High Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1985
- Variable Bioavailability of Oral MercaptopurineNew England Journal of Medicine, 1983
- THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKAEMIABritish Journal of Haematology, 1980
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- IMMUNODEPRESSANT ACTIVITY AND 6-MERCAPTOPURINE LEVELS AFTER ADMINISTRATION OF 6-MERCAPTOPURINE AND AZATHIOPRINETransplantation, 1973